Innovations in conservative and surgical therapy for Ménière's disease-narrative review
Abstract
Ménière's disease (MD) is an inner ear disorder of poorly understood etiology, and its management remains symptomatic. This review presents novel therapeutic approaches to control vertigo, improve audiological function, and enhance patient outcomes in MD. The literature was reviewed to explore conservative and surgical methods under current investigation. Recent advances in pharmacological therapy target oxidative stress, immune-mediated pathways, and neuromodulatory mechanisms. Clinical trial reports evaluating the efficacy of new oral treatment-ebselen were included. Preliminary report describing treating patients with MD and migaine with rimegepant was analyzed. Novel strategies to improve betahistine bioavailability were also reviewed. Authors reported modifications to intratympanic steroid therapy with OTO-104 and SPT-2101 (sustained-release intratympanic dexamethasone hydrogel). Contemporary surgical approaches increasingly aim to preserve hearing and, when feasible, partial vestibular function. Among surgical techniques, endolymphatic sac surgery with various modifications, endolymphatic duct blockage, canal plugging, and transcanal neurectomy were analyzed. Advances in pharmacological and surgical strategies offer new options for MD symptom control, but their effectiveness remains to be confirmed in larger, long-term trials. At the same time, these innovative therapeutic approaches provide valuable insights into the underlying pathophysiological mechanisms of the…
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.